Literature DB >> 10616225

Improving decisionmaking processes with the fuzzy logic approach in the epidemiology of sleep disorders.

M M Ohayon1.   

Abstract

Epidemiological studies can provide information not only on specific diagnostic entities but also on their underlying symptomatic constellations. For this purpose, an expert system was developed for the assessment of sleep disorders and endowed with the fuzzy logic capabilities necessary to determine the degree to which a given symptom corresponds to a specific diagnosis. Uncertainty is inherent in fields such as sleep medicine and psychiatry, and becomes evident in clinical practice at the stages of data collection and diagnostic formulation, when the clinician must determine whether a symptom is present and must choose from several diagnostic possibilities. The process involves a considerable degree of subjectivity on the part of the patient in trying to describe his or her symptoms, and of the clinician whose final diagnosis will depend on his or her clinical experience and interpretation of what is normal and what is pathological. Inferential models of the probabilistic or fuzzy logic type take into account such uncertainty. The Sleep-Eval system has been used in epidemiological and clinical studies involving 34,044 interviews collected by close to 300 interviewers. The diagnostic potential of these models is illustrated using data collected in an epidemiological study of the noninstitutionalized general population of Italy and underlines the advantages and limits of the binary, bayesian, and fuzzy logic methods and analyses.

Entities:  

Mesh:

Year:  1999        PMID: 10616225     DOI: 10.1016/s0022-3999(99)00010-0

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  12 in total

1.  Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology.

Authors:  Maurice M Ohayon; Yves Dauvilliers; Charles F Reynolds
Journal:  Arch Gen Psychiatry       Date:  2012-01

2.  Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD).

Authors:  Maurice M Ohayon; Charles F Reynolds
Journal:  Sleep Med       Date:  2009-10       Impact factor: 3.492

3.  Insomnia and the performance of US workers: results from the America insomnia survey.

Authors:  Ronald C Kessler; Patricia A Berglund; Catherine Coulouvrat; Goeran Hajak; Thomas Roth; Victoria Shahly; Alicia C Shillington; Judith J Stephenson; James K Walsh
Journal:  Sleep       Date:  2011-09-01       Impact factor: 5.849

4.  Hierarchy of insomnia criteria based on daytime consequences.

Authors:  Maurice M Ohayon; Dieter Riemann; Charles Morin; Charles F Reynolds
Journal:  Sleep Med       Date:  2011-10-28       Impact factor: 3.492

5.  Violent behavior during sleep: prevalence, comorbidity and consequences.

Authors:  Maurice M Ohayon; Carlos H Schenck
Journal:  Sleep Med       Date:  2010-10       Impact factor: 3.492

6.  Artificial Outdoor Nighttime Lights Associate with Altered Sleep Behavior in the American General Population.

Authors:  Maurice M Ohayon; Cristina Milesi
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

7.  Difficulty in resuming or inability to resume sleep and the links to daytime impairment: definition, prevalence and comorbidity.

Authors:  Maurice M Ohayon
Journal:  J Psychiatr Res       Date:  2009-03-03       Impact factor: 4.791

8.  Using difficulty resuming sleep to define nocturnal awakenings.

Authors:  Maurice M Ohayon; Andrew Krystal; Timothy A Roehrs; Thomas Roth; Michael V Vitiello
Journal:  Sleep Med       Date:  2010-01-13       Impact factor: 3.492

9.  Prevalence and comorbidity of nocturnal wandering in the U.S. adult general population.

Authors:  M M Ohayon; M W Mahowald; Y Dauvilliers; A D Krystal; D Léger
Journal:  Neurology       Date:  2012-05-15       Impact factor: 9.910

10.  Excessive sleep duration and quality of life.

Authors:  Maurice M Ohayon; Charles F Reynolds; Yves Dauvilliers
Journal:  Ann Neurol       Date:  2013-07-11       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.